NCT05177133
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05177133 |
| Title | Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus) (AuspiCiOus) |
| Acronym | AuspiCiOus |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | NLD |
CKB BOOST